由马斯克于2016年创立的Neuralink正在开发一种芯片，该芯片将植入人脑以同时记录和刺激脑活动。它旨在用于医疗应用，如治疗严重的脊髓损伤和神经系统疾病。
据《华尔街日报》采访中的埃隆·马斯克表示，Neuralink希望能在2022年获得FDA批准，首次将植入装置应用于人体，希望能恢复四肢瘫痪者的全身功能。
这位亿万富翁企业家在Twitter上澄清：“我绝对不是说我们一定能做到这一点，但我越来越相信这是可能的。”
Neuralink在2021年春季引起轰动，当时有一段视频显示一只植入了Neuralink芯片的猴子通过心灵感应玩电子游戏。
Neuralink在猴子身上表现良好，我们正在进行大量的测试，并且确认它非常安全可靠，Neuralink设备可以安全拆卸。我们希望明年能够将其应用于首批严重脊髓损伤患者，如四肢瘫痪者，前提是获得FDA批准。”
Mooer们，你们认为埃隆·马斯克真的想辞职吗？
mooer们，您认为Neuralink的脑芯片能否成功在2022年植入到人体中？您会接受这样的脑植入吗？
来源：THEJERUSALEm POSt, INSIDER

$Rivian Automotive (RIVN.US)$ is up 9.88% to $164.12 and has traded as high as $169.70 earlier in the session. Volume on RIVN is over 53M shares with several hours of trading still left.
Valuation today on Rivian moved to as high as $143B, which leaves the question of where analysts will go when the quiet period expires on December 20. The lead underwriters on the Rivian IPO were Goldman Sachs, JPMorgan and Morgan Stanley. BofA, Barclays, Deutsche Bank, Wells Fargo and a host of others participated in the underwriting. While Sell-equivalent ratings from analysts are pretty much unheard of on the first day of a quiet period expiration, other EV stocks have seen a flurry of Neutral-equivalent ratings arrive due to frothy valuations. In some cases, shares of EV high-fliers cooled off when the ratings poured in.
Other potential catalysts arrive in the early part of 2022 when Rivian starts to make some public appearances at conferences and issues the company's first earnings/production reports. There have been many share price stumbles in the EV sector when production timelines were altered due to supply chain issues, chip shortages or other hiccups.
In regard to social media interest, Google searches on Rivian, RIVN and Rivian stock are in a downtrend after the peak during the IPO.
RIVN is still a top ticker on Reddit's WallStreetBets and Stocktwits in terms of mentions. On moomoo, more people follow one-week old Rivian than 47-year old $富乐客 (FL.US)$.

一个简单的问题：
你希望在moomoo社区看到什么内容？
（我是指这里）
如果你有其他想法，请在下方评论告诉我们。
让我们一起把moomoo打造成一个更好的社区！

始终要认真做好尽职调查，进行自己的研究 :)

$Zomedica (ZOM.US)$ 我在低点买入了6000股。